FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090885521> ?p ?o ?g. }

• W2090885521 endingPage "1551" @default.
• W2090885521 startingPage "1544" @default.
• W2090885521 abstract "Patients with essential thrombocythemia may carry JAK2 (V617F), an MPL substitution, or a calreticulin gene (CALR) mutation. We studied biologic and clinical features of essential thrombocythemia according to JAK2 or CALR mutation status and in relation to those of polycythemia vera. The mutant allele burden was lower in JAK2-mutated than in CALR-mutated essential thrombocythemia. Patients with JAK2 (V617F) were older, had a higher hemoglobin level and white blood cell count, and lower platelet count and serum erythropoietin than those with CALR mutation. Hematologic parameters of patients with JAK2-mutated essential thrombocythemia or polycythemia vera were related to the mutant allele burden. While no polycythemic transformation was observed in CALR-mutated patients, the cumulative risk was 29% at 15 years in those with JAK2-mutated essential thrombocythemia. There was no significant difference in myelofibrotic transformation between the 2 subtypes of essential thrombocythemia. Patients with JAK2-mutated essential thrombocythemia and those with polycythemia vera had a similar risk of thrombosis, which was twice that of patients with the CALR mutation. These observations are consistent with the notion that JAK2-mutated essential thrombocythemia and polycythemia vera represent different phenotypes of a single myeloproliferative neoplasm, whereas CALR-mutated essential thrombocythemia is a distinct disease entity." @default.
• W2090885521 created "2016-06-24" @default.
• W2090885521 creator A5003768458 @default.
• W2090885521 creator A5004159250 @default.
• W2090885521 creator A5007091163 @default.
• W2090885521 creator A5009431793 @default.
• W2090885521 creator A5009436567 @default.
• W2090885521 creator A5017349002 @default.
• W2090885521 creator A5018792236 @default.
• W2090885521 creator A5019208096 @default.
• W2090885521 creator A5023971175 @default.
• W2090885521 creator A5028878372 @default.
• W2090885521 creator A5038763128 @default.
• W2090885521 creator A5046031381 @default.
• W2090885521 creator A5048902463 @default.
• W2090885521 creator A5050011235 @default.
• W2090885521 creator A5057393031 @default.
• W2090885521 creator A5058120698 @default.
• W2090885521 creator A5063853781 @default.
• W2090885521 creator A5064978902 @default.
• W2090885521 creator A5072484806 @default.
• W2090885521 creator A5090078781 @default.
• W2090885521 date "2014-03-06" @default.
• W2090885521 modified "2023-10-16" @default.
• W2090885521 title "JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes" @default.
• W2090885521 cites W1965359675 @default.
• W2090885521 cites W1969611600 @default.
• W2090885521 cites W1976479449 @default.
• W2090885521 cites W1979832242 @default.
• W2090885521 cites W1980568348 @default.
• W2090885521 cites W1983262956 @default.
• W2090885521 cites W1983611328 @default.
• W2090885521 cites W1985994644 @default.
• W2090885521 cites W1986853254 @default.
• W2090885521 cites W1991885817 @default.
• W2090885521 cites W1997560018 @default.
• W2090885521 cites W1998721150 @default.
• W2090885521 cites W2001006614 @default.
• W2090885521 cites W2012686883 @default.
• W2090885521 cites W2017521583 @default.
• W2090885521 cites W2038195476 @default.
• W2090885521 cites W2038981426 @default.
• W2090885521 cites W2041055738 @default.
• W2090885521 cites W2045477530 @default.
• W2090885521 cites W2049145190 @default.
• W2090885521 cites W2056171219 @default.
• W2090885521 cites W2058330063 @default.
• W2090885521 cites W2062007713 @default.
• W2090885521 cites W2067829130 @default.
• W2090885521 cites W2068302080 @default.
• W2090885521 cites W2070929302 @default.
• W2090885521 cites W2096638244 @default.
• W2090885521 cites W2110190127 @default.
• W2090885521 cites W2133633030 @default.
• W2090885521 cites W2138709799 @default.
• W2090885521 cites W2151757571 @default.
• W2090885521 cites W2157694607 @default.
• W2090885521 cites W2160219845 @default.
• W2090885521 cites W2169405856 @default.
• W2090885521 doi "https://doi.org/10.1182/blood-2013-11-539098" @default.
• W2090885521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3945864" @default.
• W2090885521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24366362" @default.
• W2090885521 hasPublicationYear "2014" @default.
• W2090885521 type Work @default.
• W2090885521 sameAs 2090885521 @default.
• W2090885521 citedByCount "484" @default.
• W2090885521 countsByYear W20908855212014 @default.
• W2090885521 countsByYear W20908855212015 @default.
• W2090885521 countsByYear W20908855212016 @default.
• W2090885521 countsByYear W20908855212017 @default.
• W2090885521 countsByYear W20908855212018 @default.
• W2090885521 countsByYear W20908855212019 @default.
• W2090885521 countsByYear W20908855212020 @default.
• W2090885521 countsByYear W20908855212021 @default.
• W2090885521 countsByYear W20908855212022 @default.
• W2090885521 countsByYear W20908855212023 @default.
• W2090885521 crossrefType "journal-article" @default.
• W2090885521 hasAuthorship W2090885521A5003768458 @default.
• W2090885521 hasAuthorship W2090885521A5004159250 @default.
• W2090885521 hasAuthorship W2090885521A5007091163 @default.
• W2090885521 hasAuthorship W2090885521A5009431793 @default.
• W2090885521 hasAuthorship W2090885521A5009436567 @default.
• W2090885521 hasAuthorship W2090885521A5017349002 @default.
• W2090885521 hasAuthorship W2090885521A5018792236 @default.
• W2090885521 hasAuthorship W2090885521A5019208096 @default.
• W2090885521 hasAuthorship W2090885521A5023971175 @default.
• W2090885521 hasAuthorship W2090885521A5028878372 @default.
• W2090885521 hasAuthorship W2090885521A5038763128 @default.
• W2090885521 hasAuthorship W2090885521A5046031381 @default.
• W2090885521 hasAuthorship W2090885521A5048902463 @default.
• W2090885521 hasAuthorship W2090885521A5050011235 @default.
• W2090885521 hasAuthorship W2090885521A5057393031 @default.
• W2090885521 hasAuthorship W2090885521A5058120698 @default.
• W2090885521 hasAuthorship W2090885521A5063853781 @default.
• W2090885521 hasAuthorship W2090885521A5064978902 @default.
• W2090885521 hasAuthorship W2090885521A5072484806 @default.
• W2090885521 hasAuthorship W2090885521A5090078781 @default.
• W2090885521 hasBestOaLocation W20908855211 @default.

• next